Norges Bank’s Boston Scientific Corp Position
Does Norges Bank own Boston Scientific Corp (BSX)? Not currently — the last reported position was 23.07M shares worth $2.2B in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2.2B
Q4 2025
Shares
23.07M
% of Portfolio
+0.24%
Quarters Held
23
position exited
Position History BSX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 23.07M | $2.2B | +0.24% |
| Q2 2025 | 19.46M | $2.1B | +0.26% |
| Q1 2025 | 17.51M | $1.2B | +0.19% |
| Q4 2024 | 19.73M | $1.8B | +0.23% |
| Q3 2024 | 14.56M | $769M | +0.16% |
| Q2 2024 | 32.27M | $2.2B | +0.18% |
| Q1 2024 | 14.06M | $704M | +0.15% |
| Q4 2023 | 16.10M | $931M | +0.16% |
| Q3 2023 | 13.33M | $516M | +0.14% |
| Q2 2023 | 12.40M | $462M | +0.12% |
| Q4 2022 | 13.67M | $633M | +0.15% |
| Q3 2022 | 13.74M | $596M | +0.13% |
| Q2 2022 | 14.18M | $606M | +0.13% |
| Q1 2022 | 14.68M | $568M | +0.13% |
| Q3 2021 | 13.54M | $517M | +0.14% |
| Q2 2021 | 13.12M | $461M | +0.13% |
| Q1 2021 | 11.96M | $390M | +0.14% |
| Q3 2020 | 14.86M | $605M | +0.19% |
| Q2 2020 | 14.55M | $626M | +0.19% |
| Q1 2020 | 14.77M | $567M | +0.18% |
| Q3 2019 | 17.90M | $689M | +0.22% |
| Q2 2019 | 17.74M | $580M | +0.20% |
| Q1 2019 | 18.61M | $509M | +0.18% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norges Bank’s full portfolio or all institutional holders of BSX.